CN105853630A - 一种治疗原发性失眠的中药组合物及制备方法 - Google Patents
一种治疗原发性失眠的中药组合物及制备方法 Download PDFInfo
- Publication number
- CN105853630A CN105853630A CN201610418089.2A CN201610418089A CN105853630A CN 105853630 A CN105853630 A CN 105853630A CN 201610418089 A CN201610418089 A CN 201610418089A CN 105853630 A CN105853630 A CN 105853630A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- parched
- cortex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 79
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 title claims abstract description 38
- 206010022437 insomnia Diseases 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 210000000582 semen Anatomy 0.000 claims abstract description 32
- 241000218176 Corydalis Species 0.000 claims abstract description 16
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 16
- 239000000052 vinegar Substances 0.000 claims abstract description 16
- 235000021419 vinegar Nutrition 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 230000033228 biological regulation Effects 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 238000001802 infusion Methods 0.000 claims description 16
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 16
- 239000012141 concentrate Substances 0.000 claims description 7
- 238000002481 ethanol extraction Methods 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 239000003390 Chinese drug Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 26
- 210000005036 nerve Anatomy 0.000 abstract description 4
- 230000003860 sleep quality Effects 0.000 abstract description 3
- 238000010926 purge Methods 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 abstract 1
- 230000004617 sleep duration Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 20
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 210000002216 heart Anatomy 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 238000002791 soaking Methods 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 230000002936 tranquilizing effect Effects 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 230000036592 analgesia Effects 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001430 anti-depressive effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 229940005513 antidepressants Drugs 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000002557 soporific effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 240000003409 Gentiana lutea Species 0.000 description 1
- 235000002873 Gentiana lutea Nutrition 0.000 description 1
- DUAGQYUORDTXOR-GPQRQXLASA-N Gentiopicrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)C2=CCOC(=O)C2=CO1 DUAGQYUORDTXOR-GPQRQXLASA-N 0.000 description 1
- DUAGQYUORDTXOR-WULZUDSJSA-N Gentiopicrin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1[C@@H](C=C)C=2C(C(=O)OCC=2)=CO1 DUAGQYUORDTXOR-WULZUDSJSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- DFNZYFAJQPLJFI-UHFFFAOYSA-N gentianine Chemical compound O=C1OCCC2=C1C=NC=C2C=C DFNZYFAJQPLJFI-UHFFFAOYSA-N 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000004799 sedative–hypnotic effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 230000008454 sleep-wake cycle Effects 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种治疗原发性失眠的中药组合物及制备方法。所述的中药包括如下组分:柴胡、龙胆草、酸枣仁、当归、炒白芍、炒枳壳、醋玄胡、川楝子、合欢皮、夜交藤、炙远志、茯神、磁石、龙骨、牡蛎、车前子、泽泻、丹皮、炒山栀。所述中药各组分按照一定配比经过浸泡、熬煮、乙醇提取,调节pH值,最后浓缩制成治疗原发性失眠的中药。所述中药具有缓解失眠,改善睡眠质量、入睡时间及睡眠持续时间,共奏疏肝解郁、泻火安神之效,可以显著治疗原发性失眠,具有治疗效果好,使用方便,且无明显毒副作用。
Description
技术领域
本发明涉及一种治疗原发性失眠的中药组合物及制备方法。
背景技术
睡眠是人类生命构成部分之一,一生中33.33%的时间是在睡眠中度过的,一旦睡眠发生障碍,人类身心健康则会产生严重影响。随着现代化生活节奏的不断加快、压力的不断加重,作为睡眠障碍类疾病发病率最高的失眠症来说,其发病率在世界各地不断上升。白天失眠患者一般有精神不振、疲乏无力等现象,有的会出现不同程度的头晕、头痛、心悸、健忘、注意力不集中等症状,伴随表现的还会有情绪焦虑、烦躁不安、极易易怒等,加重或诱发多种疾病,严重影响了人们的工作学习及生活质量。因此,失眠症不但是个医学问题,而且影响着社会和经济的发展,由此研究该领域有着深远的意义。
越来越高的失眠发病率引起了一连串的不良影响,已然成为全世界重要关注的社会公共健康问题之一。现代医学对失眠的研究主要基于对睡眠机制的探索,从神经-内分泌-网络这一层次,深入的探索研究神经器官组织到细胞分子基因水平,更深层次研究睡眠-觉醒周期。目前失眠具体病理-生理学改变及其机制尚不明确。人工合成的镇静催眠药物是现代医学对失眠症的一种有效治疗成果,但是一定程度上抑制患者的中枢神经系统,易使患者随即表现如下不良反应:依赖性、成瘾性、戒断性等。中医学对失眠症的研究历史渊源,已达数千年之久,其治疗目的的实现主要是根据失眠患者的整体状况,辨证论治,全面调节患者各个脏腑功能,以求气血阴阳平衡。目前,还没有一种特别有效治疗原发性失眠且不良反应少的中药,因此,寻找一种治疗效果好,副作用少的治疗原发性失眠中药是研究的重点所在。
发明内容
针对现有技术中的缺陷,本发明的目的是提供一种治疗原发性失眠的中药,所述中药具有缓解失眠,改善睡眠质量、入睡时间及睡眠持续时间。
本发明解决技术问题采用如下技术方案:
本发明涉及一种治疗原发性失眠的中药组合物,所述的中药包括如下重量份数的各组分:柴胡10~20份、龙胆草10~20份、酸枣仁10~30份、当归10~20份、炒白芍10~20份、炒枳壳6~12份、醋玄胡10~20份、川楝子10~15份、合欢皮10~20份、夜交藤10~15份、炙远志6~10份、茯神10~20份、磁石10~20份、龙骨10~20份、牡蛎10~20份、车前子15~30份、泽泻10~20份、丹皮10~20份、炒山栀10~20份。
优选地,所述的中药包括如下重量份数的各组分:柴胡10份、龙胆草10份、酸枣仁10份、当归10份、炒白芍10份、炒枳壳6份、醋玄胡10份、川楝子10份、合欢皮10份、夜交藤10份、炙远志6份、茯神10份、磁石10份、龙骨15份、牡蛎15份、车前子15份、泽泻10份、丹皮10份、炒山栀10份。
优选地,所述的中药包括如下重量份数的各组分:柴胡15份、龙胆草15份、酸枣仁20份、当归15份、炒白芍15份、炒枳壳10份、醋玄胡15份、川楝子12份、合欢皮15份、夜交藤15份、炙远志10份、茯神15份、磁石15份、龙骨15份、牡蛎15份、车前子20份、泽泻15份、丹皮15份、炒山栀15份
优选地,所述的中药包括如下重量份数的各组分:柴胡20份、龙胆草20份、酸枣仁30份、当归20份、炒白芍20份、炒枳壳12份、醋玄胡20份、川楝子15份、合欢皮20份、夜交藤15份、炙远志10份、茯神20份、磁石20份、龙骨20份、牡蛎20份、车前子30份、泽泻20份、丹皮20份、炒山栀20份。
本发明还提供一种治疗原发性失眠的中药组合物的制备方法,包括如下步骤:将各组分按照比例混合均匀,得中药混合物;取所述混合物,与温水混合,浸泡10~30min,之后再加入适量的水于80~100℃熬煮30~50min;冷却,加入80%~90%的乙醇提取三次,滤液调节PH为6.0~7.0,浓缩制得中药制剂。
优选地,所述温水的温度为25~30℃,所述浸泡时间为20min。
优选地,所述加入水的总重量为中药混合物重量的20倍。
优选地,所述熬煮温度为90℃,所述熬煮时间为40min。
优选地,所述加入乙醇的浓度为80%,所述加入乙醇的体积量为加入水的体积量的1~2倍。
与现有技术相比,本发明具有如下的有益效果:
本发明所述中药组合物具有疏肝解郁、清泻肝火安神的作用,用于治疗原发性失眠症,具有治疗效果好,大大减少了不良反应的发生,且使用方便,可采用多种使用方式,对不同的浓度治疗手段,各药相辅相成,且无明显毒副作用,成本低。
具体实施方式
下面结合具体实施例,进一步阐述本发明。这些实施例仅用于说明本发明而不用于限制本发明的范围。
经研究可知,肝、心功能的失调贯穿失眠症的始终,肝、心乃其发病之关键脏腑,肝郁化火尤为显著,而本发明所述方法制备的中药则恰恰是疏肝解郁、清泻肝火安神的目的。本发明的治疗原发性失眠的中药组合物,主要包括以下原料:柴胡、龙胆草、酸枣仁、当归、炒白芍、炒枳壳、醋玄胡、川楝子、合欢皮、夜交藤、炙远志、茯神、磁石、龙骨、牡蛎、车前子、泽泻、丹皮、炒山栀,其中各组分的药理药性如下:
柴胡,味苦、辛、性微寒、入肝、胆经,有解表和里、升阳、疏肝解郁的功效,还具有镇静、镇痛、抗惊厥等中枢抑制作用,有解热、镇咳、抗炎、抗病毒、降血脂、保肝利胆、抗肿瘤、抗抑郁等药理活性。
龙胆草,味苦,性寒,入肝、胆经,有清肝胆湿热、泻下焦郁火之功,常与柴胡配伍,沉降升散一升一降,泻火清阳郁滞均散,现代研究显示龙胆根主要含龙胆宁碱、龙胆苦甙及龙胆三糖等多种成分,具有刺激胃液分泌及抑菌作用。
当归,味甘、辛,性温,入心、肝、脾经,具有补血活血,调经止痛、润肠通便之功。常配伍白芍可达养血理血,柔肝止痛之效。现代研究显示当归的化学成分主要有根含挥发油,具有补血、增强免疫功能、镇痛、抗炎、抗脂质过氧化和清除氧自由基作用。当归对中枢神经系统有轻度抑制作用。
白芍,味苦、酸,性微寒,入肝、脾经,具有养血柔肝、缓解止痛的功效,现代研究显示其化学成分主要含有芍药甙、牡丹酚、芍药花甙、苯甲酸、挥发油、脂肪油、树脂、鞣质、糖、淀粉、粘液质、蛋白质、β-谷甾醇和三萜类等。具有免疫调节、镇痛、镇静、抗炎、抗抑郁等作用,同时,也对中枢神经系统有一定抑制作用。
炒枳壳,味苦,性辛,入脾、胃、大肠经,具有破气、化痰、消积、除痞之功,长于行气宽中除胀。
醋玄胡,味苦、温,性辛,具有止痛、镇静催眠、降压、扩管、抗心律失常、护肝等作用。
川楝子,味苦、性微寒,有小毒,入肝、小肠、胃、膀胱经,具有疏肝、行气、止痛、杀虫疗癣之功。
酸枣仁, 入心、脾、肝、胆经,味甘、酸,性平,具有安神养心,敛汗生津之功;
合欢皮,味甘,性平,归心、肝、肺经,具有解郁安神、活血消肿之功。
夜交藤,味甘,性平,入心、肝经,具有养血安神、祛风通络之功。
炙远志,味苦、性辛,温,入心、肾经,具有益智安神,散郁化痰,开窍、消肿解毒之功。
茯神,味甘、淡,性平,入心、脾、肾经,具有宁心安神的功效。专用于心神不安、惊悸、健忘等。具有镇静催眠、利水消肿、抑制肿瘤、抗炎抑菌、调节免疫、改善脑代谢功能等作用。
磁石,入肾、肝、肺经,味咸、性寒,具有平肝潜阳,聪耳明目,镇惊安神,纳气平喘之功。
龙骨,入心、肝、肾、大肠经,性甘平、味涩,具有镇静、敛汗涩精、生肌敛疮等作用,能够改善失眠的持续时间。
牡蛎,味咸、性微寒,具有重镇安神,潜阳补阴,软坚散结,收敛固涩之功。
车前子,入肾、膀胱经,味甘,性微寒,具有清热、明目、利尿、祛痰之功,具有利尿、降血脂、祛痰镇咳、抗炎、抗肿瘤等作用。
泽泻,入肾、膀胱经,味甘,性寒,具有去水利尿,渗湿,清热之功效,具有利尿作用、抑制动脉粥样硬化、降压、抗高血脂和抗心肌缺血等作用。
丹皮,入心、肝、肾经,味苦、性辛,微寒,具有清热凉血,活血散瘀之功,具有解热、抗过敏、镇痛、镇静、催眠、降压、保肝、防虫、免疫调节、防腐等作用。
炒山栀,入心、肝、肺、胃、三焦经,味苦,性寒,具有泻火解毒、清热利湿、凉血散瘀的功效。
实施例1:
本实施例涉及一种治疗原发性失眠的中药组合物及制备方法;
所述的中药由如下组分组成:柴胡10份、龙胆草10份、酸枣仁10份、当归10份、炒白芍10份、炒枳壳6份、醋玄胡10份、川楝子10份、合欢皮10份、夜交藤10份、炙远志6份、茯神10份、磁石10份、龙骨15份、牡蛎15份、车前子15份、泽泻10份、丹皮10份、炒山栀10份。
所述中药制备步骤如下:将各组分按照比例混合均匀,再将混合均匀的中药材一次放入25℃温水浸泡20min,之后加入适量水于90℃熬煮40min,使得水的总重量为中药重量的20倍;将熬煮的中药材冷却,加入80%与水等体积的乙醇提取三次,滤液调节PH至6.0~7.0,浓缩制得中药制剂。
实施例2:
本实施例涉及一种治疗原发性失眠的中药中药组合物及制备方法;
所述的中药由如下组分组成:柴胡15份、龙胆草15份、酸枣仁20份、当归15份、炒白芍15份、炒枳壳10份、醋玄胡15份、川楝子12份、合欢皮15份、夜交藤15份、炙远志10份、茯神15份、磁石15份、龙骨15份、牡蛎15份、车前子20份、泽泻15份、丹皮15份、炒山栀15份。
所述中药制备步骤如下:将各组分按照比例混合均匀,再将混合均匀的中药材一次放入25℃温水浸泡20min,之后加入适量水于90℃熬煮40min,使得水的总重量为中药重量的20倍;将熬煮的中药材冷却,加入80%与水等体积的乙醇提取三次,滤液调节PH至6.0~7.0,浓缩制得中药制剂。
实施例3:
本实施例涉及一种治疗原发性失眠的中药组合物及制备方法;
所述的中药由如下组分组成:柴胡20份、龙胆草20份、酸枣仁30份、当归20份、炒白芍20份、炒枳壳12份、醋玄胡20份、川楝子15份、合欢皮20份、夜交藤15份、炙远志10份、茯神20份、磁石20份、龙骨20份、牡蛎20份、车前子30份、泽泻20份、丹皮20份、炒山栀20份。
所述中药制备步骤如下:将各组分按照比例混合均匀,再将混合均匀的中药材一次放入25℃温水浸泡20min,之后加入适量水于90℃熬煮40min,使得水的总重量为中药重量的20倍;将熬煮的中药材冷却,加入80% 2倍水的体积量的乙醇提取三次,滤液调节PH至6.0~7.0,浓缩制得中药制剂。
实施例4:
本实施例涉及一种治疗原发性失眠的中药组合物及制备方法;
所述的中药由如下组分组成:柴胡10份、龙胆草10份、酸枣仁10份、当归10份、炒白芍10份、炒枳壳6份、醋玄胡10份、川楝子10份、合欢皮10份、夜交藤10份、炙远志6份、茯神10份、磁石10份、龙骨10份、牡蛎10份、车前子15份、泽泻10份、丹皮10份、炒山栀10份。
所述中药制备步骤如下:将各组分按照比例混合均匀,再将混合均匀的中药材一次放入25℃温水浸泡20min,之后加入适量水于80℃熬煮50min,使得水的总重量为中药重量的20倍;将熬煮的中药材冷却,加入80%与水等体积的乙醇提取三次,滤液调节PH至6.0~7.0,浓缩制得中药制剂
实施例5:
本实施例涉及一种治疗原发性失眠的中药组合物及制备方法;
所述的中药由如下组分组成:柴胡12份、龙胆草12份、酸枣仁15份、当归10份、炒白芍10份、炒枳壳6份、醋玄胡12份、川楝子10份、合欢皮10份、夜交藤10份、炙远志8份、茯神10份、磁石10份、龙骨15份、牡蛎15份、车前子15份、泽泻10份、丹皮12份、炒山栀10份。
所述中药制备步骤如下:将各组分按照比例混合均匀,再将混合均匀的中药材一次放入30℃温水浸泡20min,之后加入适量水于100℃熬煮30min,使得水的总重量为中药重量的20倍;将熬煮的中药材冷却,加入80%与水等体积的乙醇提取三次,滤液调节PH至6.0~7.0,浓缩制得中药制剂
取上述实施例制备的中药,进行疗效验证。每组患者10人,服用1个疗程之后效果见下表:
症状 | 严重程度 | 效果 |
失眠 | 严重 | 得到较好改善,能够较快入睡 |
多梦 | 严重 | 少梦,睡眠质量提高 |
睡眠浅 | 严重 | 得到较好改善,能够进入深度睡眠 |
通过上述实施例可以看出,本发明使用中药组合物的治疗方式,治疗效果好,大大减少了不良反应的发生,且使用方便,各药相辅相成,对于改善肝豆状核变性有显著疗效,且无明显毒副作用,成本低。
以上对本发明的具体实施例进行了描述。需要理解的是,本发明并不局限于上述特定实施方式,本领域技术人员可以在权利要求的范围内做出各种变形或修改,这并不影响本发明的实质内容。
Claims (9)
1.一种治疗原发性失眠的中药组合物,其特征在于:所述的中药包括如下重量份数的各组分:柴胡10~20份、龙胆草10~20份、酸枣仁10~30份、当归10~20份、炒白芍10~20份、炒枳壳6~12份、醋玄胡10~20份、川楝子10~15份、合欢皮10~20份、夜交藤10~15份、炙远志6~10份、茯神10~20份、磁石10~20份、龙骨10~20份、牡蛎10~20份、车前子15~30份、泽泻10~20份、丹皮10~20份、炒山栀10~20份。
2.根据权利要求1所述的治疗原发性失眠的中药组合物,其特征在于:所述的中药包括如下重量份数的各组分:柴胡10份、龙胆草10份、酸枣仁10份、当归10份、炒白芍10份、炒枳壳6份、醋玄胡10份、川楝子10份、合欢皮10份、夜交藤10份、炙远志6份、茯神10份、磁石10份、龙骨15份、牡蛎15份、车前子15份、泽泻10份、丹皮10份、炒山栀10份。
3.根据权利要求1所述的治疗原发性失眠的中药组合物,其特征在于:所述的中药包括如下重量份数的各组分:柴胡15份、龙胆草15份、酸枣仁20份、当归15份、炒白芍15份、炒枳壳10份、醋玄胡15份、川楝子12份、合欢皮15份、夜交藤15份、炙远志10份、茯神15份、磁石15份、龙骨15份、牡蛎15份、车前子20份、泽泻15份、丹皮15份、炒山栀15份。
4.根据权利要求1所述的治疗原发性失眠的中药组合物,其特征在于:所述的中药包括如下重量份数的各组分:柴胡20份、龙胆草20份、酸枣仁30份、当归20份、炒白芍20份、炒枳壳12份、醋玄胡20份、川楝子15份、合欢皮20份、夜交藤15份、炙远志10份、茯神20份、磁石20份、龙骨20份、牡蛎20份、车前子30份、泽泻20份、丹皮20份、炒山栀20份。
5.一种根据权利要求1~4中任一项所述治疗原发性失眠的中药组合物的制备方法,其特征在于:包括如下步骤:将各组分按照比例混合均匀,得中药混合物;取所述混合物,与温水混合,浸泡10~30min,之后再加入适量的水于80~100℃熬煮30~50min;冷却,加入80%~90%的乙醇提取三次,滤液调节PH为6.0~7.0,浓缩制得中药制剂。
6.根据权利要求5所述治疗原发性失眠的中药组合物的制备方法,其特征在于:所述温水的温度为25~30℃,所述浸泡时间为20min。
7.根据权利要求5所述治疗原发性失眠的中药组合物的制备方法,其特征在于:所述加入水的总重量为中药混合物重量的20倍。
8.根据权利要求5所述治疗原发性失眠的中药组合物的制备方法,其特征在于:所述熬煮温度为90℃,所述熬煮时间为40min。
9.根据权利要求5所述治疗原发性失眠的中药组合物的制备方法,其特征在于:所述加入乙醇的浓度为80%,所述加入乙醇的体积量为加入水的体积量的1~2倍。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610418089.2A CN105853630A (zh) | 2016-06-15 | 2016-06-15 | 一种治疗原发性失眠的中药组合物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610418089.2A CN105853630A (zh) | 2016-06-15 | 2016-06-15 | 一种治疗原发性失眠的中药组合物及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105853630A true CN105853630A (zh) | 2016-08-17 |
Family
ID=56650493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610418089.2A Pending CN105853630A (zh) | 2016-06-15 | 2016-06-15 | 一种治疗原发性失眠的中药组合物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105853630A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115350256A (zh) * | 2022-08-10 | 2022-11-18 | 广东药科大学 | 一种治疗失眠的中药组合物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104623536A (zh) * | 2015-01-15 | 2015-05-20 | 刘昌红 | 一种治疗失眠的中药组合物 |
-
2016
- 2016-06-15 CN CN201610418089.2A patent/CN105853630A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104623536A (zh) * | 2015-01-15 | 2015-05-20 | 刘昌红 | 一种治疗失眠的中药组合物 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115350256A (zh) * | 2022-08-10 | 2022-11-18 | 广东药科大学 | 一种治疗失眠的中药组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105194565A (zh) | 一种用于治疗心脏神经症的中药丸剂及制备方法 | |
CN103316224B (zh) | 具有补肝肾、益精血、健脑明目的中药制剂 | |
CN104873745A (zh) | 一种治疗失眠的中药及制备方法 | |
CN103520505A (zh) | 一种治疗神经衰弱的中药制剂及制备方法 | |
CN102247552A (zh) | 心脑血管葛根山药胶囊 | |
CN102512633A (zh) | 一种治疗不寐的中药组合物 | |
CN112675281A (zh) | 一种用于治疗抑郁症和失眠症的泡脚汤 | |
CN107397939A (zh) | 一种用于治疗神经衰弱的中药配方 | |
CN106511762A (zh) | 一种补肾壮阳的玛咖保健酒及其制备方法 | |
CN105561002A (zh) | 一种艾叶保健足浴粉及其制备方法 | |
CN106075311A (zh) | 一种用于治疗神经衰弱的中药组合物 | |
Mann et al. | Ayurveda: A new dimension in the era of modern medicine | |
CN105853630A (zh) | 一种治疗原发性失眠的中药组合物及制备方法 | |
CN104547598A (zh) | 一种治疗神经衰弱的中药制剂及制备方法 | |
CN104189778A (zh) | 一种用于乳腺增生的中药制剂及其制备方法 | |
CN101953990B (zh) | 一种动力波视康仪及中药组合物 | |
CN103751711A (zh) | 一种抗抑郁症的中药汤剂 | |
CN103446310B (zh) | 一种治疗腰腿痛的中药药浴及其制备方法 | |
CN102973687B (zh) | 调节妇女内分泌平衡的口服液 | |
CN111632115A (zh) | 一种运动舒缓精油及其制备方法 | |
CN101401906A (zh) | 一种治疗失眠的安神口服液 | |
CN104189867A (zh) | 一种治疗精神分裂症后抑郁的中药组合物 | |
CN104524235A (zh) | 一种治疗心脏神经症中药组合物 | |
CN104547642A (zh) | 一种治疗女性纤维肌痛综合征的中药组合物 | |
CN107349395A (zh) | 用于治疗神经衰弱的中药配方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160817 |
|
RJ01 | Rejection of invention patent application after publication |